ArticlePloS one2016

Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes.

John A Olsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.